Research
Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital
Published

Hypovolemia and reduced hemoglobin mass in patients with heart failure and preserved ejection fraction

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. Metformin does not compromise energy status in human skeletal muscle at rest or during acute exercise: A randomised, crossover trial

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. An exploration of the methods to determine the protein-specific synthesis and breakdown rates in vivo in humans

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Acute intramyocardial lipid accumulation in rats does not slow cardiac conduction per se

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Age-dependent impairment of the erythropoietin response to reduced central venous pressure in HFpEF patients

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Copeptin, a surrogate marker for arginine vasopressin secretion, is positively associated with glucagon

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Transcriptome analysis in patients with temporal lobe epilepsy

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Cardiac dysfunction in cirrhosis: a 2-yr longitudinal follow-up study using advanced cardiac imaging

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. ProANP and proBNP in plasma as biomarkers of heart failure

    Research output: Contribution to journalJournal articleResearchpeer-review

  • David Montero
  • Thomas Haider
  • Jens Barthelmes
  • Jens P Goetze
  • Silviya Cantatore
  • Isabella Sudano
  • Frank Ruschitzka
  • Andreas J Flammer
View graph of relations

A fundamental tenet of heart failure (HF) pathophysiology hinges on a propensity for fluid retention leading to blood volume (BV) expansion and hemodilution. Whether this can be applied to heart failure patients with preserved ejection fraction (HFpEF) remains uncertain. The present study sought to determine BV status and key hormones regulating fluid homeostasis and erythropoiesis in HFpEF patients. BV and hemoglobin mass (Hbmass ) were determined with high-precision, automated carbon monoxide (CO) rebreathing in 20 stable HFpEF patients (71.5 ± 7.3 years, left ventricular ejection fraction = 55.7 ± 4.0%) and 15 healthy age- and sex-matched control individuals. Additional measurements comprised key circulating BV-regulating hormones such as pro-atrial natriuretic peptide (proANP), copeptin, aldosterone and erythropoietin (EPO), as well as central hemodynamics and arterial stiffness via carotid-femoral pulse wave velocity (PWV). Carotid-femoral PWV was increased (+20%) in HFpEF patients versus control individuals. With respect to hematological variables, plasma volume (PV) did not differ between groups, whereas BV was decreased (-14%) in HFpEF patients. In consonance with the hypovolemic status, Hbmass was reduced (-27%) in HFpEF patients, despite they presented more than a twofold elevation of circulating EPO (+119%). Plasma concentrations of BV-regulating hormones, including proANP (+106%), copeptin (+99%), and aldosterone (+62%), were substantially augmented in HFpEF patients. HFpEF patients may present with hypovolemia and markedly reduced Hbmass , underpinned by a generalized overactivation of endocrine systems regulating fluid homeostasis and erythropoiesis. These findings provide a novel perspective on the pathophysiological basis of the HFpEF condition.

Original languageEnglish
Article numbere14222
JournalPhysiological Reports
Volume7
Issue number21
ISSN2051-817X
DOIs
Publication statusPublished - Nov 2019

ID: 58367629